Idera Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary

Aceragen

30/04/2021 04:49

* Idera Pharmaceuticals Inc  IDRA.OQ  reported a quarterly
adjusted loss of 14 cents​​ per share for the quarter ended
in March. The mean expectation of four analysts for the quarter
was for a loss of 21 cents per share.
* Revenue was $0.00​​;  analysts expected $0.00.
* Idera Pharmaceuticals Inc's reported EPS for the quarter was a
loss of 14 cents​.
* The mean earnings estimate of analysts had fallen by
about 95.5% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Idera Pharmaceuticals Inc shares had fallen by 3.8% this
quarter and lost 65.9% so far this year.
* The company reported a quarterly loss of $10.05 million.
* Wall Street's median 12-month price target for Idera
Pharmaceuticals Inc is $1.50 
* The current average analyst rating on the shares is "hold" and
the breakdown of recommendations is no "strong buy" or "buy," 4
"hold" and no "sell" or "strong sell." 
This summary was machine generated April 30 at 03:49 a.m. GMT.
​All figures in US Dollars.​